F-group (family)
2007.1.12.1 DHquinase_II
Ligands and drugs
955
Member domains
542
with ligand contacts (≤ 4 Å)
56.8% of members
533
with DrugDomain annotations
55.8% of members
336
with a DrugBank compound
35.2% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 2007.1.12.1 belongs to X-group 2007 Flavodoxin-like, which binds 8.9 ligand superclasses per 20 proteins, broader than 77% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB02801 | FA1 | 2,3-Anhydro-quinic acid | 49 |
| DB09459 | TLA | L-tartaric acid | 37 |
| DB04656 | CA2 | 1,3,4-TRIHYDROXY-5-(3-PHENOXYPROPYL)-CYCLOHEXANE-1-CARBOXYLIC A CID | 13 |
| DB01694 | TAR | D-tartaric acid | 12 |
| DB02786 | FA3 | 2-Anhydro-3-Fluoro-Quinic Acid | 12 |
| DB08485 | RP4 | (1S,4S,5S)-1,4,5-TRIHYDROXY-3-[3-(PHENYLTHIO)PHENYL]CYCLOHEX-2-ENE-1-CARBOXYLIC ACID | 12 |
| DB03868 | DQA | 3-Dehydroquinic Acid | 5 |
| DB04347 | 3DS | 3-Dehydroshikimate | 5 |
| DB03345 | BME | Mercaptoethanol | 4 |
| DB00133 | SER | Serine | 1 |
| DB03434 | MPO | 3-(N-morpholino)propanesulfonic acid | 1 |
| DB03739 | FA6 | 3-Hydroxyimino Quinic Acid | 1 |
| DB04332 | ETE | 2-{2-[2-2-(Methoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethanol | 1 |
| DB04698 | GAJ | N-(1,4-dihydro-5H-tetrazol-5-ylidene)-9-oxo-9H-xanthene-2-sulfonamide | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CL | CHLORIDE ION | 55 |
| FA1 | 2,3 -ANHYDRO-QUINIC ACID | 49 |
| TLA | L(+)-TARTARIC ACID | 37 |
| 1R2 | 3-hydroxy-5-(3-nitrophenoxy)benzoic acid | 24 |
| KIU | 5-[(3-nitrobenzyl)oxy]benzene-1,3-dicarboxylic acid | 24 |
| KIW | 5-[(3-nitrobenzyl)amino]benzene-1,3-dicarboxylic acid | 24 |
| N87 | (1R,4R,5R)-1,4,5-trihydroxy-3-[3-(phenylcarbonyl)phenyl]cyclohex-2-ene-1-carboxylic acid | 24 |
| RJP | (1R,5R)-1,5-dihydroxy-4-oxo-3-[3-oxo-3-(phenylamino)propyl]cyclohex-2-ene-1-carboxylic acid | 24 |
| D1X | 2,6-dioxo-1,2,3,6-tetrahydropyridine-4-carboxylic acid | 23 |
| N88 | (1R,4R,5R)-3-(tert-butylcarbamoyl)-1,4,5-trihydroxycyclohex-2-ene-1-carboxylic acid | 15 |
| CA2 | (1S,3R,4R,5S)-1,3,4-TRIHYDROXY-5-(3-PHENOXYPROPYL)CYCLOHEXANECARBOXYLIC ACID | 13 |
| DHK | 3-DEHYDROSHIKIMATE | 12 |
| FA3 | 2-ANHYDRO-3-FLUORO-QUINIC ACID | 12 |
| RP4 | (1S,4S,5S)-1,4,5-TRIHYDROXY-3-[3-(PHENYLTHIO)PHENYL]CYCLOHEX-2-ENE-1-CARBOXYLIC ACID | 12 |
| TAR | D(-)-TARTARIC ACID | 12 |
| DQA | 1,3,4-TRIHYDROXY-5-OXO-CYCLOHEXANECARBOXYLIC ACID | 11 |
| NAmetal | SODIUM ION | 9 |
| CB6 | (1R,4S,5R)-1,4,5-trihydroxy-3-[(5-methyl-1-benzothiophen-2-yl)methoxy]cyclohex-2-ene-1-carboxylic acid | 7 |
| 2HN | (1R,2S,4S,5R)-2-(2,3,4,5,6-pentafluorophenyl)methyl-1,4,5-trihydroxy-3-oxocyclohexane-1-carboxylic acid | 6 |
| 3DS | (4S,5R)-4,5-dihydroxy-3-oxocyclohex-1-ene-1-carboxylic acid | 5 |